Benzinga | Mar 25, 2021 04:06PM EDT

Biolase Q4 EPS $(0.07) Misses $(0.04) Estimate, Sales $8.50M Beat $8.34M Estimate

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.04) by 75 percent. This is a 46.15 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $8.50 million which beat the analyst consensus estimate of $8.34 million by 1.92 percent. This is a 16.52 percent decrease over sales of $10.18 million the same period last year.